HIV Preexposure Prophylaxis (PrEP)
10 questions
Questions in Topic
- 1. Medication Options for HIV PrEP
- 2. Baseline Laboratory Evaluation
- 3. Long-Acting Injectable Cabotegravir-IM
- 4. Monitoring Renal Function on Oral PrEP
- 5. HIV Testing while on HIV PrEP
- 6. HIV PrEP for Persons who Inject Drugs
- 7. HIV PrEP and Drug-Resistant HIV
- 8. Side Effects of HIV PrEP Medications
- 9. HIV PrEP Options for Women
- 10. On-Demand HIV PrEP
Learning Objectives
- List persons to consider who may benefit from HIV PrEP
- Explain recommendations for testing and counseling prior to starting HIV PrEP
- Discuss the recommended HIV PrEP regimens, including dosing, safety, efficacy, and clinical eligibility
- Describe recommended clinical and laboratory baseline evaluation and monitoring for persons receiving HIV PrEP
- Summarize initial management of persons who develop HIV while receiving HIV PrEP
Authors
Reviewers
3rd Edition
This is a substantial revision of the original Question Bank Topic. The previous edition was titled HIV Preexposure Prophylaxis (PrEP) 2nd Edition Question Bank and was available until August 31st, 2023.
CNE/CME
Continuing Education
This lesson qualifies for:
View CE Notices
- 1.0 CME AMA PRA Category 1 Credit™, or
- 1.0 CNE contact hour and 1.0 CE contact hour (qualifies for pharmacology CE for advanced practice nurses)
CNE and CME Origination: July 1st, 2017
CNE and CME Review: September 1st, 2023
CNE and CME Expiration: August 31st, 2026 (3rd Edition)
View CE Notices
Steps to acquire a Certificate for this Lesson:
1
Answer Questions
Answer the board-review style questions
2
Answer Correctly
Score 80% on questions
3
Give Feedback
Complete survey
4
Print Certificate
Document work Explore this topic in detail in the HIV Preexposure Prophylaxis (PrEP) Quick Reference,
or earn more CE for it in the HIV Preexposure Prophylaxis (PrEP) Self-Study
or earn more CE for it in the HIV Preexposure Prophylaxis (PrEP) Self-Study